The association of pretransplant heartmate ii left ventricular assist device placement and heart transplantation mortality

ASAIO Journal

Volumn 60, Issue 3, 2014, Pages 294-299

  Donneyong, Macarius ^a   Cheng, Allen ^a   Trivedi, Jaimin R ^a   Schumer, Erin ^a   McCants, Kelly C ^a   Birks, Emma J ^a   Slaughter, Mark S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Heart transplantation; HeartMate; left ventricular assist device; mortality

Indexed keywords

LEFT VENTRICULAR ASSIST DEVICES; REGRESSION ANALYSIS;

CONFIDENCE INTERVAL; DESCRIPTIVE STATISTICS; HEART TRANSPLANTATION; HEARTMATE; LEFT VENTRICULAR ASSIST DEVICE (LVAD); MORTALITY; STANDARD DEVIATION; STATISTICALLY SIGNIFICANT DIFFERENCE;

HEART VALVE PROSTHESES;

ADULT; AGED; ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DONOR; FEMALE; GRAFT RECIPIENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY; ADOLESCENT; HEART ASSIST DEVICE; HEART VENTRICLE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900461680     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000065     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121: e46-e215, 2010.
2. Taylor DO,Edwards LB,Boucek MM,et al Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant rep ort-2007. J Heart Lung Transplant, 26, 769-781, 2007.
3. O? Connell JB, Bourge RC, Costanzo-Nordin M R, et al: Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association . Circulation 86: 1061-1079, 1992.
4. Uriel N, Jorde UP, Woo Pak S, et al: Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. J Heart Lung Transplant 32: 188 -195, 2013.
5. Rose EA, Gelijns AC, Moskowitz AJ, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-te rm use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
6. Lietz K, Long JW, Kfoury AG, et al: Outcomes of left ventricular assist device implan tation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 116: 497-505, 2007.
7. Slaughter MS, Pagani FD, Rogers JG, et al; HeartMate II Clinical Investig ators: Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29(4 suppl): S1-S39, 2010.
8. Pagani FD, Miller LW, Russell SD, et al; Hea rtMate II Investigators: Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54: 312-321, 2009.
9. Kirklin JK, Naftel DC, Kormos RL, et al: Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32: 141- 156, 2013.
10. Patlolla V, Patten RD, Denofrio D, Konstam MA, Krishnamani R: The effect of ventricular assist devices on post-transplant mortality an analysis of the United Network for Organ Sharing thoracic registry. J Am Co ll Cardiol 53: 264-271, 2009.
11. John R, Pagani FD, Naka Y, et al: Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ven tricular assist device support and other variables. J Thorac Cardiovasc Surg 140: 174- 181, 2010.
12. Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K: Postcardiac tra nsplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg 145: 575- 581, 2013.
13. Urban M, Pirk J, Dorazilova Z, Netuka I: How does successful bridging with ventricular assist device affect cardiac transplantation outcome Interact Cardiovasc Thorac Surg 13: 405 -409, 2011.
14. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007.
15. Slaughter MS, Rogers JG, Milano CA, et al ; HeartMate II Investigators: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361: 2241-2251, 2009.
16. Farrar DJ, Hill JD: Recovery of major organ functi on in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 13: 1125-1132, 1994.
17. Friedel N, Viazis P, Schiessler A, et al: Recovery of end-organ failure during mechanical circulatory support. Eur J Cardiothorac Surg 6: 519-522; discussion 523, 1992.
18. Gronda EG , Barbieri P, Frigerio M, et al: Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support. J Heart Lung Transplant 18: 654-6 63, 1999.